LIFZYLUM Trademark

Trademark Overview

On Friday, March 2, 2018, a trademark application was filed for LIFZYLUM with the United States Patent and Trademark Office. The USPTO has given the LIFZYLUM trademark a serial number of 87817521. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Bristol-Myers Squibb Company. The LIFZYLUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
lifzylum

General Information

Serial Number87817521
Word MarkLIFZYLUM
Filing DateFriday, March 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 5 GRANTED
Friday, October 8, 2021SOU EXTENSION 5 FILED
Friday, October 8, 2021TEAS EXTENSION RECEIVED
Thursday, April 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 30, 2021SOU EXTENSION 4 GRANTED
Tuesday, March 30, 2021SOU EXTENSION 4 FILED
Tuesday, March 30, 2021TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 3 GRANTED
Friday, October 9, 2020SOU EXTENSION 3 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 11, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, November 10, 2020EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 10, 2020PETITION TO REVIVE-GRANTED
Tuesday, November 10, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, November 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 9, 2020SOU EXTENSION 2 GRANTED
Thursday, April 9, 2020SOU EXTENSION 2 FILED
Thursday, April 9, 2020TEAS EXTENSION RECEIVED
Friday, October 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 9, 2019SOU EXTENSION 1 FILED
Wednesday, October 9, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 16, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Saturday, June 16, 2018PRIORITY ACTION E-MAILED
Saturday, June 16, 2018PRIORITY ACTION WRITTEN
Friday, June 15, 2018ASSIGNED TO EXAMINER
Friday, March 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 6, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lifzylum diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection